These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19442654)

  • 1. Proliferative and anti-proliferative effects of thymosin alpha1 on cells are associated with manipulation of cellular ROS levels.
    Qin Y; Chen FD; Zhou L; Gong XG; Han QF
    Chem Biol Interact; 2009 Aug; 180(3):383-8. PubMed ID: 19442654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-proliferative effects of the novel squamosamide derivative (FLZ) on HepG2 human hepatoma cells by regulating the cell cycle-related proteins are associated with decreased Ca(2+)/ROS levels.
    Qin Y; Pan X; Tang TT; Zhou L; Gong XG
    Chem Biol Interact; 2011 Sep; 193(3):246-53. PubMed ID: 21835169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The anti-tumor efforts of thymosin alpha1 on tumor lysate-pulsed dendritic cells in colon cancer in vitro and in vivo].
    Ma YL; Zheng Z; Li BD; Xie SJ; Li GX; Yan QH; Cai JH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Nov; 23(11):1046-9. PubMed ID: 17988589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A modified thymosin alpha 1 inhibits the growth of breast cancer both in vitro and in vivo: suppressment of cell proliferation, inducible cell apoptosis and enhancement of targeted anticancer effects.
    Lao X; Li B; Liu M; Shen C; Yu T; Gao X; Zheng H
    Apoptosis; 2015 Oct; 20(10):1307-20. PubMed ID: 26283169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory and enhanced antitumor activity of a modified thymosin α1 in melanoma and lung cancer.
    Wang F; Li B; Fu P; Li Q; Zheng H; Lao X
    Int J Pharm; 2018 Aug; 547(1-2):611-620. PubMed ID: 29933059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymosin alpha1 suppresses proliferation and induces apoptosis in human leukemia cell lines.
    Fan YZ; Chang H; Yu Y; Liu J; Wang R
    Peptides; 2006 Sep; 27(9):2165-73. PubMed ID: 16644063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tumor-penetrating peptide modification enhances the antitumor activity of thymosin alpha 1.
    Lao X; Liu M; Chen J; Zheng H
    PLoS One; 2013; 8(8):e72242. PubMed ID: 23977262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a C-end rule modification on antitumor activity of thymosin α1.
    Wang F; Xu C; Peng R; Li B; Shen X; Zheng H; Lao X
    Biochimie; 2018 Nov; 154():99-106. PubMed ID: 30096371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymosin α1 promotes the activation of myeloid-derived suppressor cells in a Lewis lung cancer model by upregulating Arginase 1.
    Yuan C; Zheng Y; Zhang B; Shao L; Liu Y; Tian T; Gu X; Li X; Fan K
    Biochem Biophys Res Commun; 2015 Aug; 464(1):249-55. PubMed ID: 26111447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression, purification and characterization of a novel soluble human thymosin alpha1 concatemer exhibited a stronger stimulation on mice lymphocytes proliferation and higher anti-tumor activity.
    Li W; Song L; Wu S; Xue X; Zhang L; He L; Han W; Wang Q; Ling R; Zhang W; Yan Z; Zhang Y
    Int J Biol Sci; 2011; 7(5):618-28. PubMed ID: 21647330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in vivo immunomodulatory and synergistic anti-tumor activity of thymosin α1-thymopentin fusion peptide and its binding to TLR2.
    Li J; Cheng Y; Zhang X; Zheng L; Han Z; Li P; Xiao Y; Zhang Q; Wang F
    Cancer Lett; 2013 Sep; 337(2):237-47. PubMed ID: 23684552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal growth inhibition as a bioassay for thymosin alpha1: inactivation of Talpha1 by trifluroacetic acid.
    Bianco-Batlles D; Naylor CW; Moshier JA; Dosescu J; Naylor PH
    Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):157-60. PubMed ID: 11292250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the immunomodulating peptide thymosin alpha 1 on multiple myeloma and immune recovery after hematopoietic stem cell transplantation.
    Binsfeld M; Hannon M; Otjacques E; Humblet-Baron S; Baudoux E; Beguin Y; Baron F; Caers J
    Cancer Immunol Immunother; 2015 Aug; 64(8):989-98. PubMed ID: 25971542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-proliferative effects of recombinant iron superoxide dismutase on HepG2 cells via a redox-dependent PI3k/Akt pathway.
    Lu M; Bi CS; Gong XG; Chen HM; Sheng XH; Deng TL; Xu KD
    Appl Microbiol Biotechnol; 2007 Aug; 76(1):193-201. PubMed ID: 17387468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopharmacology of thymosin alpha1 and cytokine synergy.
    Naylor PH; Quadrini K; Garaci E; Rasi G; Hadden JW
    Ann N Y Acad Sci; 2007 Sep; 1112():235-44. PubMed ID: 17567942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymosin alpha1. SciClone Pharmaceuticals.
    Billich A
    Curr Opin Investig Drugs; 2002 May; 3(5):698-707. PubMed ID: 12090542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymosin alpha-1-transformed Bifidobacterium promotes T cell proliferation and maturation in mice by oral administration.
    Shao C; Tian G; Huang Y; Liang W; Zheng H; Wei J; Wei C; Yang C; Wang H; Zeng W
    Int Immunopharmacol; 2013 Mar; 15(3):646-53. PubMed ID: 23352493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of thymosin alpha1-thymopentin fusion peptide in Pichia pastoris and its characterization.
    Gao D; Zhang X; Zhang J; Cao J; Wang F
    Arch Pharm Res; 2008 Nov; 31(11):1471-6. PubMed ID: 19023544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymosin-alpha1 modulates dendritic cell differentiation and functional maturation from human peripheral blood CD14+ monocytes.
    Yao Q; Doan LX; Zhang R; Bharadwaj U; Li M; Chen C
    Immunol Lett; 2007 Jun; 110(2):110-20. PubMed ID: 17532057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The modulation of thymosin alpha 1 in the maturation, differentiation and function of murine bone marrow-derived dendritic cells in the absence or presence of tumor necrosis factor-alpha.
    Huang Y; Chen Z; Zhou C; Yao H; Li M; Xu C
    Int Immunopharmacol; 2004 Apr; 4(4):539-46. PubMed ID: 15099531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.